BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37169258)

  • 21. Malignant transformation of hepatic adenomas.
    Micchelli ST; Vivekanandan P; Boitnott JK; Pawlik TM; Choti MA; Torbenson M
    Mod Pathol; 2008 Apr; 21(4):491-7. PubMed ID: 18246041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis.
    Margolskee E; Bao F; de Gonzalez AK; Moreira RK; Lagana S; Sireci AN; Sepulveda AR; Remotti H; Lefkowitch JH; Salomao M
    Diagn Pathol; 2016 Mar; 11():27. PubMed ID: 26961851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a unique gene expression signature that differentiates hepatocellular adenoma from well-differentiated hepatocellular carcinoma.
    Chen ZM; Crone KG; Watson MA; Pfeifer JD; Wang HL
    Am J Surg Pathol; 2005 Dec; 29(12):1600-8. PubMed ID: 16327432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of an immunohistochemical panel consisting of glypican-3, heat-shock protein-70, and glutamine synthetase in the distinction of low-grade hepatocellular carcinoma from hepatocellular adenoma.
    Lagana SM; Salomao M; Bao F; Moreira RK; Lefkowitch JH; Remotti HE
    Appl Immunohistochem Mol Morphol; 2013 Mar; 21(2):170-6. PubMed ID: 22914605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exome analysis of the evolutionary path of hepatocellular adenoma-carcinoma transition, vascular invasion and brain dissemination.
    Vilarinho S; Erson-Omay EZ; Mitchell-Richards K; Cha C; Nelson-Williams C; Harmancı AS; Yasuno K; Günel M; Taddei TH
    J Hepatol; 2017 Jul; 67(1):186-191. PubMed ID: 28323122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Focal β-catenin mutation identified on formalin-fixed and paraffin-embedded inflammatory hepatocellular adenomas.
    Saldarriaga J; Bisig B; Couchy G; Castain C; Zucman-Rossi J; Balabaud C; Sempoux C; Bioulac-Sage P
    Histopathology; 2017 Dec; 71(6):989-993. PubMed ID: 28618047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of xenobiotic and steroid hormone metabolizing enzymes in hepatocellular tumors of the non-cirrhotic liver.
    Haas S; Merkelbach-Bruse S; Justenhoven C; Brauch H; Fischer HP
    Pathol Res Pract; 2009; 205(10):716-25. PubMed ID: 19596526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular classification of hepatocellular adenoma in clinical practice.
    Nault JC; Paradis V; Cherqui D; Vilgrain V; Zucman-Rossi J
    J Hepatol; 2017 Nov; 67(5):1074-1083. PubMed ID: 28733222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subtype classification of hepatocellular adenoma.
    Bioulac-Sage P; Balabaud C; Zucman-Rossi J
    Dig Surg; 2010; 27(1):39-45. PubMed ID: 20357450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TERT promoter mutations in primary liver tumors.
    Nault JC; Zucman-Rossi J
    Clin Res Hepatol Gastroenterol; 2016 Feb; 40(1):9-14. PubMed ID: 26336998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatocellular adenomas in the Turkish population: reclassification according to updated World Health Organization criteria.
    Deniz K; Umetsu SE; Ferrell L; Yılmaz F; Güllüoğlu M; Sağol Ö; Doğusoy GB; Kırımlıoğlu H; Turhan N; Doran F; Kepil N; Çelikel ÇA; Nart D; Özgüven BY; Ceyran B; Karadağ N; Kır G; Erden E; Yılmaz G; Akyol G
    Histopathology; 2021 Jul; 79(1):23-33. PubMed ID: 33406290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene mutations in hepatocellular adenomas.
    Raft MB; Jørgensen EN; Vainer B
    Histopathology; 2015 Jun; 66(7):910-21. PubMed ID: 25195525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocellular nodules expressing markers of hepatocellular adenomas in Budd-Chiari syndrome and other rare hepatic vascular disorders.
    Sempoux C; Paradis V; Komuta M; Wee A; Calderaro J; Balabaud C; Quaglia A; Bioulac-Sage P
    J Hepatol; 2015 Nov; 63(5):1173-80. PubMed ID: 26119687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation.
    Pilati C; Letouzé E; Nault JC; Imbeaud S; Boulai A; Calderaro J; Poussin K; Franconi A; Couchy G; Morcrette G; Mallet M; Taouji S; Balabaud C; Terris B; Canal F; Paradis V; Scoazec JY; de Muret A; Guettier C; Bioulac-Sage P; Chevet E; Calvo F; Zucman-Rossi J
    Cancer Cell; 2014 Apr; 25(4):428-41. PubMed ID: 24735922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive Patterns of Glutamine Synthetase Immunohistochemical Staining in CTNNB1-mutated Hepatocellular Adenomas.
    Sempoux C; Gouw ASH; Dunet V; Paradis V; Balabaud C; Bioulac-Sage P
    Am J Surg Pathol; 2021 Apr; 45(4):477-487. PubMed ID: 33560657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignant transformation of a β-catenin inflammatory adenoma due to an S45 β-catenin-activating mutation present 12 years before.
    Sempoux C; Bisig B; Couchy G; Balabaud C; Zucman-Rossi J; Bioulac-Sage P
    Hum Pathol; 2017 Apr; 62():122-125. PubMed ID: 27984126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathologic characterization of hepatocellular adenomas in men: a multicenter experience.
    González IA; Torbenson M; Sharifai N; Byrnes K; Chatterjee D; Kakar S; Yeh MM; Wu TT; Zhang X; Jain D
    Hum Pathol; 2023 Aug; 138():24-33. PubMed ID: 37245629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocellular adenoma management: call for shared guidelines and multidisciplinary approach.
    Blanc JF; Frulio N; Chiche L; Sempoux C; Annet L; Hubert C; Gouw AS; de Jong KP; Bioulac-Sage P; Balabaud C
    Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):180-7. PubMed ID: 25434466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural history of liver adenomatosis: A long-term observational study.
    Barbier L; Nault JC; Dujardin F; Scotto B; Besson M; de Muret A; Bourlier P; Zucman-Rossi J; Salamé E; Bacq Y
    J Hepatol; 2019 Dec; 71(6):1184-1192. PubMed ID: 31419515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Somatic HNF1A mutations in the malignant transformation of hepatocellular adenomas: a retrospective analysis of data from MSK-IMPACT and TCGA.
    Hechtman JF; Abou-Alfa GK; Stadler ZK; Mandelker DL; Roehrl MHA; Zehir A; Vakiani E; Middha S; Klimstra DS; Shia J
    Hum Pathol; 2019 Jan; 83():1-6. PubMed ID: 30121369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.